Your browser doesn't support javascript.
loading
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab.
Jacquinot, Quentin; Meneveau, Nathalie; Falcoz, Antoine; Bouhaddi, Malika; Roux, Pauline; Degano, Bruno; Chatot, Marion; Curtit, Elsa; Mansi, Laura; Paillard, Marie-Justine; Bazan, Fernando; Chaigneau, Loïc; Dobi, Erion; Meynard, Guillaume; Vernerey, Dewi; Pivot, Xavier; Mougin, Fabienne.
  • Jacquinot Q; Regional Federative Cancer Institute of Franche-Comté, Besançon, France.
  • Meneveau N; Research Unit EA3920, University of Franche-Comté, Besançon, France.
  • Falcoz A; Department of Medical Oncology, University Hospital, Besançon, France.
  • Bouhaddi M; UMR 1098, Methodology and Quality of Life Unit in Oncology, University Hospital, Besançon, France.
  • Roux P; Research Unit EA3920, University of Franche-Comté, Besançon, France.
  • Degano B; Physiology-Functional Explorations, University Hospital, Besançon, France.
  • Chatot M; Physiology-Functional Explorations, University Hospital, Besançon, France.
  • Curtit E; Heart-Lung Unit, Department of Physiology-Functional Explorations, University Hospital, Grenoble, France.
  • Mansi L; Department of Cardiology, University Hospital, Besançon, France.
  • Paillard MJ; Department of Medical Oncology, University Hospital, Besançon, France.
  • Bazan F; INSERM UMR 1098, Host-Graft-Tumor Interaction, Cell and Gene Engineering, University of Franche-Comté, Besançon, France.
  • Chaigneau L; Department of Medical Oncology, University Hospital, Besançon, France.
  • Dobi E; INSERM UMR 1098, Host-Graft-Tumor Interaction, Cell and Gene Engineering, University of Franche-Comté, Besançon, France.
  • Meynard G; Department of Medical Oncology, University Hospital, Besançon, France.
  • Vernerey D; Department of Medical Oncology, University Hospital, Besançon, France.
  • Pivot X; Department of Medical Oncology, University Hospital, Besançon, France.
  • Mougin F; Department of Medical Oncology, University Hospital, Besançon, France.
Front Cardiovasc Med ; 9: 1000846, 2022.
Article en En | MEDLINE | ID: mdl-36211552
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article